Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report

Autor: Oliver Beuing, Michaela Butryn, Jens Neumann, Christian D. Muller, Eugen Feist, Sabine Mewes

Publikováno v: BMC Neurology, Vol 21, Iss 1, Pp 1-3 (2021)
BMC neurology 21(1), 228 (2021). doi:10.1186/s12883-021-02231-7
BMC Neurology

Backround We describe one of the first cases of a Posterior reversible encephalopathy syndrome (PRES) under tocilizumab as treatment of Giant cell arteritis (GCA). Case presentation A 65-year-old female with known GCA and treatment with Tocilizumab (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca7408c3c8521dff527c683884f9a482
https://doaj.org/article/9c215b3ed2194618ae302ad4c0aeffdd